I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. …

Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device cou…

I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from …

We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families manag…

In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at…

In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders…

Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially elimi…

We explore Android APS (AAPS)—a powerful open-source automated insulin delivery system that runs on Android phones and uses the advanced o-ref algorithm. AAPS offers features like Dynamic ISF (Insulin Sensitivity Factor), Dynamic CR (Carb Ratio), Unannounced Meal detection (UAM), and Super Micro Boluses (SMBs), making it one of the most customizabl…

The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pha…

Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam! We dive into the highly anticipated Twiist pump, the newly unveiled and more powerful Kaleido 2, Tandem’s game-changing Control IQ+ algorithm update, Dexcom’s 15-day sensor, and more. This was a HUGE week for diabetes innovation…

The ADA’s Standards of Care shape diabetes treatment, technology access, and insurance coverage worldwide. In this episode, we break down the latest updates, including a major new recommendation that all people with type 2 diabetes—regardless of insulin use—have access to CGM. We also explore the ADA’s stance on emerging diabetes technologies and w…

DIY Loop is one of the most powerful and customizable automated insulin delivery systems for type 1 diabetes, offering features like overrides, retroactive carb adjustments, and glycemic index logging. In this episode, fellow Loop user Jake Giles joins me to share our experiences getting started, the support (or lack thereof) from doctors, and a de…

Sernova’s innovative Cell Pouch implants insulin-producing cells, and early trials have helped some people achieve full insulin independence for years. But challenges like immunosuppressants and scalability remain. In this episode, I’m joined by Jonathan Rigby, CEO of Sernova and a fellow T1D, to discuss how this technology works, the life-changing…

In the aftermath of the devastating January 2025 Los Angeles fires, a grassroots group of volunteers, led by You’re Just My Type, sprang into action to deliver life-saving medical supplies to people with type 1 diabetes. Liz Van Horhis, who had only planned to visit L.A. for a dog-sitting trip, found herself at the heart of the relief effort. She s…

For decades, people with type 1 diabetes have heard that a cure is just “5-10 years away” – yet here we are, still waiting. Many have grown skeptical, but after this conversation, you might just walk away with hope! Journalist and fellow T1D Ginger Vieira joins me to break down the latest breakthroughs in diabetes cure research. From companies that…

2025 is set to bring major advancements in diabetes technology, from AI-driven CGMs to new insulin pumps like Medtronic’s upcoming 8-series and patch pump, and the Tidepool Loop-based twiist pump. I spoke with Gary Scheiner, a CDCES and author of Think Like a Pancreas, to break down what these innovations mean for diabetes management. Learn about O…

The Beta Bionics iLet insulin pump continues to impress with rapid updates like an upgraded design, expanded CGM integrations, and the sleek Blue Circle Follower App. I sit down with Beta Bionics’ Chief Product Officer, Mike Mensinger—known for his work on the Dexcom Follow feature and InPen smart insulin pen—to explore the iLet’s new features, inc…

Parenting a child with type 1 diabetes is no easy feat, and in this episode, Shannon Boggs shares her journey raising her 10-year-old daughter. From diagnosis to navigating school, sports, and independence, Shannon offers insights into fostering resilience and managing challenges like 504 plans and emotions. We also explore the role their diabetes …

In this episode, we dive into the mental and social toll of living with type 1 diabetes, exploring the feelings of stigma, shame, and constant need for explanation that often accompany the condition. Joining me is my friend Jake Giles, who has lived with T1D since age 16 and wrote a powerful piece for Beyond Type 1 about the isolation and embarrass…

I sat down the Founder of Qvin to explore a groundbreaking device that uses menstrual blood to monitor biomarkers for conditions like cervical cancer, fertility, thyroid health, STIs, and more. Already making waves, Qvin’s FDA-cleared test for A1C measures average blood glucose over three months using a pad-like device during a menstrual cycle, wit…

Today we dive into a head-to-head comparison of two leading automated insulin delivery (AID) systems, viewed through the lens of someone who has lived with diabetes since the 1950s. Our guest, Michael Dardenelle, shares his firsthand experience transitioning from the Tandem t:slim X2 and Dexcom G7 to the Medtronic 780g and Guardian 4 CGM, offering …

Michael Dardenelle was diagnosed with type 1 diabetes in 1956. In this episode, he reflects on the remarkable evolution of diabetes treatment and technology over the decades, while sharing his personal health challenges, including living with neuropathy. Michael’s journey is both inspiring and insightful—a must-watch for anyone interested in diabet…

From skyrocketing insurance premiums to record-high coverage denials by companies like United Healthcare, we explore why the $5 trillion US healthcare system lacks transparency and leaves consumers paying more for less. I'm joined by Jeff Delverne, Director of Payer Relations at Beta Bionics to unpack industry consolidation, the role of PBMs in dri…

From big partnerships like Dexcom and Oura, and Abbott with Medtronic, to the development of an all-in-one insulin pump, 2024 was a year of major advancements in diabetes technology. In this episode, I explore the game-changing collaborations between industry giants and their potential impact, a new insulin pump bringing a DIY algorithm to the main…

I spoke with Mary Williams about what its like managing her type 1 diabetes while teaching the 5th grade. We also get into her diagnosis and diabetes tech journey, and dive deeper into what it's like using the Tandem t:slim X2 pump and smartphone app. Please fill out our 2024 Diabetech Podcast Survey Learn about Omnipod 5 (today's sponsor)* T1D Exc…

Could a tiny, tubeless insulin pump designed for overnight use transform diabetes management? Enter Luna—a semi-reusable pump, offering automated insulin delivery to keep glucose levels steady while you sleep. Designed for MDI users but potentially valuable for pumpers, Luna is heading to pivotal trials with promising results. I sat down with John …

The Kaleido pump is the prettiest automated insulin deilvery (AID) pump I have ever seen! I spoke with Nina Joakim (aka @DiaBadass_Nina on social), who has been using Kaleido for the past three months. She shares her journey of 17 years with Medtronic pumps, her experiences with other AID systems, and why she ultimately chose Kaleido. We dive into …

Eversense 365 is an implantable continuous glucose monitor (CGM) that last one year. I sat down with leaders of Asencia and Senseonics to learn about the upgrades for the latest Eversense model, how the new sensor and transmitter are different, when we can expect it to connect with insulin pumps, and the improvements they are focused on next. Are y…

CGM's are officially available over-the-counter in the US and I dive into everything you need to know. We discuss Dexcom's Stelo, meant for people with pre-diabetes or type 2 diabetes not using insulin, and Abbott's Lingo, designed for people without diabetes. We dive into how these biosensors work and the pros and cons of the information and feedb…

Inreda's dual-hormone pump is designed to function as a true artificial pancreas—no more bolusing, carb counting, or prepping for workouts required. I had the opportunity to sit down with Inreda's Founder and CEO, Robin Koops, to dive deep into the technology behind this groundbreaking device. We explore how the pump's advanced algorithm autonomous…

I've been using the Omnipod 5 system for three months, and today I'm diving into my experience! In this video, I’ll walk you through the Omnipod 5 iPhone app, share my favorite areas to wear it, and talk about my transition from open-source systems to this FDA-cleared option. I’ll also cover how I manage workouts, the settings tweaks I've made, and…

A new insulin pump, the MODD-1, has received FDA clearance and is expected to release early next year. In this episode I sit down with Modular Medical CEO, Jeb Besser, to discuss the origins of the pump, how its modular two-part system works, and who it's designed for. T1D Exchange Registry Sign up (US only) Join our Newsletter | Diabetech Communit…

Welcome to the second part of our deep dive into open-source diabetes management apps like DIY Loop, Trio, and AAPS. In this episode, we explore how each app's algorithm functions, their unique features, and the customization options they provide. We also break down which app might be the best fit for you based on ease of setup and functionality. I…

Curious about DIY insulin delivery systems like Loop, Trio, or AAPS? Our expert panel dives into the world of open-source Automated Insulin Delivery (AID) systems, exploring advanced features that FDA-approved systems can’t match! Learn how to build and customize these apps, unlock advanced features like Caregiver Controls, Siri Shortcuts, Geofenci…

In this episode, I dive into the latest diabetes tech and research from EASD 2024. We explore everything from all-in-one CGM and pump prototypes to an exciting dual-hormone pump used by 250 people, set to launch in 2026. I also take a closer look at the Kaliedo pump and its Diabeloop algorithm. Plus, I break down new research on how the Medtronic 7…

Why are so many endocrinologists burning out and leaving traditional medicine behind? Endo and artist Dr. Mike Natter shares an inside look at why many, including himself, are feeling overworked and exhausted. From grueling 70-hour work weeks to skipping meals and bathroom breaks, the pressure is relentless. Dr. Natter dives into the challenges of …

Trio, a new automated insulin delivery system built by the open-source community, has officially launched as an evolution of iAPS. Trio offers improvements with a focus on safety and community feedback. I’m joined by two key admins of Trio, to discuss its future advancements, including a sleek redesign, faster performance, and expanded caregiver fu…

I spoke with Veronica Elsea, who has been blind since birth, about her experiences using diabetes technology as a blind person. We also discuss how her organization, The Accessible Insulin Pump Task Force, is collaborating with the industry to make diabetes tech more accessible for the visually impaired community. T1D Exchange Registry Sign up (US …

MARD (Mean Absolute Relative Difference) is often linked to continuous glucose monitor accuracy, but did you know there’s no universal standard for how companies measure it? In this episode, Tim Street from Diabettech dives into the lack of regulation in CGM clinical trials, revealing how manufacturers might manipulate MARD to appear more accurate.…

CamAPS FX is the latest FDA cleared automated insulin delivery system for ages 2 and up, including during pregnancy. This app connects with a CGM and insulin pump to automate insulin delivery, simplifying diabetes management. Used in 17 European countries and expanding to New Zealand and Canada, CamAPS FX was developed by Dr. Roman Hovorka after 20…

From longer wear times and more tubeless pump options to fully closed loop automated insulin systems, the future of insulin pumps looks bright. David Ahn and I dive into the innovations we’ll see in pump technology and what it all means. Find a Doctor on ZocDoc (today's sponsor) T1D Exchange Registry Sign up (US only) Join our Newsletter | Diabetec…

CeQur Simplicity is an innovative insulin patch designed to function like traditional insulin injections. This device is applied directly to the user's body, delivering 2 units of insulin with each click through its cannula. It is intended for meal coverage and correction doses, complementing long-acting insulin. I had the opportunity to speak with…

Users are reporting they are unable to re-download the Dexcom G7 app outside their country. This is due to geofencing built into the smartphone app blocking users from downloading their home-country G7 app while abroad. If you plan to travel outside your country, here's what you should know and how to prepare if you use Dexcom G7. T1D Exchange Regi…

The UK's NICE guidelines represent the first time a country has made hybrid closed-loop widely available to its citizens through national healthcare. The groundbreaking guidelines instruct access to be granted to people with type 1 diabetes who fit a broad criteria over the next five years. How does health insurance work where you live? Comment on …

I list off the tech I'm most excited about from the ADA's Scientific Sessions. I cover cgms like the Libre 3 Plus that now works with pumps and the latest Dexcom G7 upgrades. I get into pumps from the Omnipod iPhone app, the CeQur insulin patch, and the Luna overnight AID insulin pump. And I get into updates from the Vertex stem cell therapy findin…

60% of Type 1 diabetes diagnoses are 20 years and older. This form of diabetes is known as LADA - Latent Autoimmune Diabetes for Adults. Today's guest and I both have LADA and were diagnosed in our 30s. Today I'm joined by Dr. Christon Darden who is sharing her diagnosis story for the first time and tells us how she handles T1D as an Orthopedic Sur…

I spoke with Marwan Elwaraki and Salwa Al-Alami, the creators of the Sweet Dreams app. This app allows you to view your CGM readings on your lock screen, amongst other things. We spoke about how this idea came to be, all of the details surrounding the use of he app, and what the future holds. T1D Exchange Registry Sign up (US residents only) Join o…

CEO Kevin Sayer explains Dexcom's has a new sensor policy, connection upgrades coming to Dexcom G7 - longer range and "Rapid Reconnect," and more. Follow our Youtube and social pages for more coverage of ADA 2024! T1D Exchange Registry Sign up (US residents only) Join our Newsletter | Diabetech Community Discord Join Patreon for Exclusive Content F…

I spoke with Paul Reid, an outdoor T1D content creator, and user of the Eversense Implantable CGM. He shares his experience with the Eversense E3 sensor so far, explains the procedure process, accuracy and calibrations, and explains why Eversense is wildly different from any CGM system on the market. Find a Doctor on ZocDoc Thanks to our sponsor, Z…

I spoke with fellow T1D content creator and host of the Diabetic Doing Things podcast, Rob Howe, about his experience with the MiniMed 780G system and how he has built a community for people with type 1. Rob shares his diabetes tech journey, all of the details on the 780G system and how it has worked for him, taking a pump break and using the Medtr…